Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11495959 | 0.95 | TSHR (0.35) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL9051338 | 0.91 | TSHR (0.35) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL9682713 | 0.91 | GAA (0.38) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL13875068 | 0.90 | GAA (0.43) | KMT2AGAAMEN1TSHRHTT | |
| Suxemerid SCHEMBL2779070 | 0.89 | SMN1; SMN2 (0.39) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL12934427 | 0.88 | KMT2A (0.32) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL17914693 | 0.87 | MEN1 (0.31) | KMT2AGAAMEN1SMN1; SMN2TP53 | |
| SCHEMBL10156172 | 0.87 | CHRM2 (0.37) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL6714702 | 0.86 | TSHR (0.37) | KMT2AGAAMEN1TSHRHTT | |
| SCHEMBL9355720 | 0.85 | KMT2A (0.31) | KMT2AGAAMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240072425-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-11873438-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-11834599-B2 | Aromatic isothiocyanates | MERCK PATENT GMBH (DE) | 2023-12-05 | — | — | US | disclosed |
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230357637-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| US-11802243-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2023-10-31 | — | — | US | disclosed |
| US-20230323209-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230323207-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-11781069-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2023-10-10 | — | — | US | disclosed |
| US-20080051306-A1 | Lubricant composition | CIBA CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-7332105-B2 | Synergistic UV absorber combination | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-19 | — | — | US | disclosed |
| US-20080033080-A1 | Stabilization of Polyether Polyol, Polyester Polyol or Polyurethane Compositions | BASF SE (DE) | 2008-02-07 | — | — | US | disclosed |
| WO-2007101549-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007028527-A1 | STABILIZATION OF IODINE BIOCIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-15 | — | — | WO | disclosed |
| US-5514767-A | Hot-melt polycondensation method for manufacturing a polycarbonate composition | GENERAL ELECTRIC COMPANY (US) | 1996-05-07 | — | — | US | disclosed |
| US-4293468-A | Malonate derivatives as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1981-10-06 | — | — | US | disclosed |
| US-4238613-A | IMPARTING PHOTOSTABILITY AND OXIDATION AND HEAT RESISTANCE TO PLASTICS | CIBA-GEIGY CORPORATION (US) | 1980-12-09 | — | — | US | disclosed |
| US-4198334-A | HEAT, LIGHT, OXIDATION RESISTANCE, PLASTICS | CIBA-GEIGY CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| US-4154722-A | PHOTOSTABILITY | CIBA-GEIGY CORPORATION (US) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240072425-A1 | AROMATIC ISOTHIOCYANATES | TRPA1, TRPC1, CRY1 | KMT2A 903/4885GAA 4417/4885MEN1 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.